Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV-1 Tat specific factor 1 pseudogene 2 (HTATSF1P2) is designated as a pseudogene. Pseudogenes are typically non-functional sequences of genomic DNA originally derived from functional genes but rendered inactive due to mutations or truncations. HTATSF1P2 lacks evidence of encoding a functional protein and is not known to play a direct biological or pathological role, nor is it a therapeutic target. It should not be confused with the functional gene HIV-1 Tat specific factor 1 (HTATSF1), which encodes a cofactor involved in transcriptional elongation and RNA splicing in the context of HIV replication[1][5]. The pseudogene status indicates that HTATSF1P2 does not have the molecular characteristics or biological functions of the canonical HTATSF1 protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 Tat specific factor 1 pseudogene 2 (HTATSF1P2).